Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemica…
| Métrica | EVGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -6.3% | 57.4% | -63.6% |
| Operating Margin | -364.2% | -34.4% | -329.9% |
| Net Margin | -220.2% | -32.5% | -187.8% |
| FCF Margin | -353.9% | -12.6% | -341.3% |
| ROE | — | -39.2% | — |
| ROA | -42.3% | -30.9% | -11.4% |
| Current Ratio | 4.54 | 2.73 | +1.81 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -42.3% | — |
| ✗Flujo de caja operativo positivo | −$14M | −$20M |
| ✗Rentabilidad sobre activos al alza | -42.3% | -41.4% |
| ✗Caja operativa/activos supera al ROA | -67.4% | ROA -42.3% |
| –Menos deuda a largo plazo | — | — |
| ✓Mejor liquidez (ratio corriente) | 4.54 | 1.15 |
| ✗Sin aumentar el nº de acciones | 8M | 6M |
| ✗Margen bruto al alza | -6.3% | 57.3% |
| ✓Rotación de activos al alza | 0.19 | 0.14 |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | -353.9% |
| ✗ROCE > 10 % | -84.5% |
| ✓Ventas > 5 %/año (3 años) | 32.0% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 211.0% |
Evogene Ltd. cotiza a 0.39 USD y tiene una capitalización bursátil de $6M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud